CRO support for ncats medicinal chemistry for lead optimization.

Ended Awarded Last action

Contract number
75N95019D00028
Awardee
Awarding agency
Task orders
1 $1,000 obligated

Award facts

Opportunity
Combined order value
$1,000 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$17,891,012.00
Maximum order
$17,887,012.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation. The contract, valued at up to $17,891,012, is to provide CRO (contract research organization) support services for NCATS's Medicinal Chemistry for Lead Optimization program.

Under this multiple-award IDC, Alchem Laboratories will perform a variety of preclinical and manufacturing services to support NCATS's drug discovery and development efforts, including custom organic synthesis, cGMP manufacturing, and analytical testing. The initial task order, valued at $1,000, is for a contract kickoff conference call. Alchem Laboratories is an experienced pharmaceutical manufacturer that has previously supported other NIH institutes through similar IDC vehicles focused on therapeutic development for cancer, HIV/AIDS, and infectious disease threats. This contract represents another avenue for the company to leverage its expertise in support of NCATS's translational research mission.

Task orders

Transactions

Action Obligated Date
Terminate for Convenience P00004 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI notice of termination for convenience… $0
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $4,000
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95019D00028?

75N95019D00028 was awarded to Alchem Laboratories Corporation by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2019.

How much is contract 75N95019D00028 worth?

Orders under 75N95019D00028 have obligated $1,000. 75N95019D00028's own ceiling is $17,891,012. A single order can be worth up to $17,887,012.

How many orders have been placed under contract 75N95019D00028?

1 order has been placed under 75N95019D00028, the latest on September 26, 2019.

Which agency awarded contract 75N95019D00028?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019D00028, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract 75N95019D00028?

75N95019D00028 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95019D00028 part of a contract vehicle?

Yes. 75N95019D00028 is part of CRO Support for NCATS Medicinal Chemistry for Lead Optimization.

Was contract 75N95019D00028 competed?

The extent of competition for 75N95019D00028 was full and open competition. The government received 13 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV